Tiagabine Level
Synonyms |
|
||||||||
Cerner Name |
|||||||||
Clinical Info |
Mayo Code: FGTIA |
||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||
Specimen Types |
Blood |
||||||||
Specimen Volume |
3 mL serum ( 0.6 mL min) |
||||||||
Container |
10ml Red Top |
||||||||
Collection Instructions |
Container/Tube: Red Top Tube |
||||||||
Transport Instructions |
Refrigerated |
||||||||
Specimen Stability |
72 Hours Room Temperature |
||||||||
Methodology |
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) |
||||||||
Days Performed |
|||||||||
Performing Laboratories |
|
||||||||
CPT |
80199 |
||||||||
PDM |
5911039 |
||||||||
Results |
|
||||||||
Result Interpretation
Report Limit: 5.0 ng/mL
Reference Range: <235.0 ng/mL Therapeutic and toxic ranges have not been established. Peak concentrations are expected at 45 minutes post dose; steady state is generally attained within 2 days. Observed tiagabine concentrations in clinical trials (30 – 56 mg/day): <1 – 234 ng/mL. Measured tiagabine concentrations, post marketing (95% confidence interval): 0 – 440 ng/mL. |
|||||||||
Forms |
|
||||||||

